Collaborating for Change: CIHP EngagesGlobal Experts at IAS 2025 in Kigali
In July 2025, CIHP joined global leaders, researchers, policymakers, and advocates at the 13th International AIDS Society (IAS) Conference on HIV Science (IAS 2025) held in Kigali, Rwanda. The five-day event served as a platform for advancing cutting-edge scientific discovery, sharing innovative solutions, and shaping policies that place people at the heart of the HIV response.
The IAS 2025 Conference convened over 4000 leading minds from around the world to accelerate HIV research and advocacy. With its strong emphasis on educating changemakers and ensuring that global responses remain grounded in science, the conference offered a valuable platform for organizations like CIHP to showcase best practices, build strategic collaborations, and adopt innovative approaches to enhance the quality of care for people living with and affected by HIV.
Critical learnings from the conference included the recommendation by WHO on long-acting injectable drug Lenacapavir for HIV prevention following results of almost100% efficacy, as well as the use of artificial intelligence (AI) in advancing prevention. CIHP highlighted its work in prevention, treatment, and health systems strengthening, offering insights from its extensive program implementation across Nigeria.
The Centre for Integrated Health Programs (CIHP) is a multi-funded indigenous not-for-profit, non-governmental organization established in 2010 to promote better health outcomes for all Nigerians through sustainable partnerships and locally adapted, rigorously tested approaches by applying our collective learnings and experiences. .
CIHP - Centre for Integrated Health Programs: is a leading indigenous not-for-profit non-governmental organization, promoting better health outcomes for all Nigerians through the creation of sustainable systems and partnerships by applying our collective learnings and experiences.
Plot 1129 Kikuyu Close, Off Nairobi Street Wuse 2, Abuja
Reader Discussion & Comments (0)
No comments yet. Be the first to share your thoughts on this story!
Leave a Comment